FluWatch report: November 6 to November 12, 2016 (week 45)
Organization: Public Health Agency of Canada
Date published: 2016-11-18
Related Topics
Overall Summary
- Influenza activity is at interseasonal levels with the majority regions in Canada reporting no activity.
- A total of 181 positive influenza detections were reported in week 45. Influenza A(H3N2) continues to be the most common subtype detected.
- In week 45, 1.6% of visits to sentinel healthcare professionals were due to influenza-like symptoms, a slight increase from week 44.
- Two laboratory-confirmed influenza outbreaks were reported in week 45, a decrease from the previous week.
- Sixteen hospitalizations were reported from participating Provinces and Territories in week 45; all due to influenza A. Less than five ICU admissions have been reported in week 45.
- To date, the majority of pediatric hospitalizations reported were due to Influenza A(H3N2).
- For more information on the flu, see our Flu(influenza) web page.
On this page
- Influenza/Influenza-like Illness (ILI) Activity (geographic spread)
- Laboratory Confirmed Influenza Detections
- Syndromic/Influenza-like Illness Surveillance
- Influenza Outbreak Surveillance
- Provincial/Territorial Influenza Hospitalizations and Deaths
- Sentinel Hospital Influenza Surveillance
- Influenza Strain Characterizations
- Antiviral Resistance
- Provincial and International Influenza Reports
- FluWatch definitions for the 2016-2017 season
Influenza/Influenza-like Illness (ILI) Activity (geographic spread)
In week 45, a total of 29 regions reported no influenza activity. Sporadic influenza activity was reported in 18 regions across seven provinces (BC, AB, SK, MB, ON,QC and NL). Localized activity was reported in six regions across four provinces/territories (YK, BC, AB and ON). For more details on a specific region, click on the map.
Laboratory Confirmed Influenza Detections
The percentage of tests positive for influenza increased in week 45 but remained at interseasonal levels, with 4.4% of tests positive for influenza. For data on other respiratory virus detections, see the Respiratory Virus Detections in Canada Report on the Public Health Agency of Canada (PHAC) website.
Figure 2 - Text Description
Report Week | A(Unsubtyped) | A(H3) | A(H1)pdm09 | Influenza B |
---|---|---|---|---|
35 | 0 | <5 | 0 | 0 |
36 | <5 | 0 | <5 | 9 |
37 | <5 | 17 | 0 | <5 |
38 | 11 | 28 | <5 | <5 |
39 | 14 | 41 | <5 | 7 |
40 | 0 | 47 | <5 | <5 |
41 | 10 | 31 | 0 | <5 |
42 | 14 | 49 | <5 | 6 |
43 | 16 | 76 | <5 | <5 |
44 | 23 | 106 | <5 | 9 |
45 | 68 | 108 | <5 | 11 |
46 | 0 | 0 | 0 | 0 |
47 | 0 | 0 | 0 | 0 |
48 | 0 | 0 | 0 | 0 |
49 | 0 | 0 | 0 | 0 |
50 | 0 | 0 | 0 | 0 |
51 | 0 | 0 | 0 | 0 |
52 | 0 | 0 | 0 | 0 |
1 | 0 | 0 | 0 | 0 |
2 | 0 | 0 | 0 | 0 |
3 | 0 | 0 | 0 | 0 |
4 | 0 | 0 | 0 | 0 |
5 | 0 | 0 | 0 | 0 |
6 | 0 | 0 | 0 | 0 |
7 | 0 | 0 | 0 | 0 |
8 | 0 | 0 | 0 | 0 |
9 | 0 | 0 | 0 | 0 |
10 | 0 | 0 | 0 | 0 |
11 | 0 | 0 | 0 | 0 |
12 | 0 | 0 | 0 | 0 |
13 | 0 | 0 | 0 | 0 |
14 | 0 | 0 | 0 | 0 |
15 | 0 | 0 | 0 | 0 |
16 | 0 | 0 | 0 | 0 |
17 | 0 | 0 | 0 | 0 |
18 | 0 | 0 | 0 | 0 |
19 | 0 | 0 | 0 | 0 |
20 | 0 | 0 | 0 | 0 |
21 | 0 | 0 | 0 | 0 |
22 | 0 | 0 | 0 | 0 |
23 | 0 | 0 | 0 | 0 |
24 | 0 | 0 | 0 | 0 |
25 | 0 | 0 | 0 | 0 |
26 | 0 | 0 | 0 | 0 |
27 | 0 | 0 | 0 | 0 |
28 | 0 | 0 | 0 | 0 |
29 | 0 | 0 | 0 | 0 |
30 | 0 | 0 | 0 | 0 |
31 | 0 | 0 | 0 | 0 |
32 | 0 | 0 | 0 | 0 |
33 | 0 | 0 | 0 | 0 |
34 | 0 | 0 | 0 | 0 |
Nationally in week 45, there were 181 positive influenza tests. Influenza A(H3N2) was the most common subtype detected. BC, AB and ON accounted for the majority (81%) of influenza detections in week 45. To date, influenza A(H3N2) is the most common subtype detected, representing 63% of laboratory-confirmed detections. For more detailed weekly and cumulative influenza data, see the text descriptions for Figures 2 and 3 or the Respiratory Virus Detections in Canada Report.
Figure 3 - Text Description
Reporting provincesTable Figure 3 - Footnote 1 |
Weekly (October 30, 2016 to November 5, 2016) | Cumulative (August 28, 2016 to November 5, 2016) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Influenza A | B | Influenza A | B | A & B Total |
|||||||
A Total |
A (H1)pdm09 |
A (H3) |
ATable Figure 3 - Footnote UnS | B Total |
A Total |
A (H1)pdm09 |
A (H3) |
ATable Figure 3 - Footnote UnS | B Total |
||
BC | 46 | 0 | 46 | 0 | 2 | 214 | 2 | 211 | 1 | 10 | 224 |
AB | 63 | 0 | 38 | 25 | 3 | 201 | 2 | 170 | 29 | 13 | 214 |
SK | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MB | 1 | 0 | 1 | 0 | 0 | 9 | 0 | 9 | 0 | 1 | 10 |
ON | 38 | 2 | 16 | 20 | 2 | 134 | 7 | 80 | 47 | 15 | 149 |
QC | 17 | 0 | 3 | 14 | 2 | 56 | 0 | 4 | 52 | 9 | 65 |
NB | 1 | 0 | 0 | 1 | 0 | 4 | 0 | 2 | 2 | 0 | 4 |
NS | 1 | 0 | 0 | 1 | 0 | 4 | 0 | 1 | 3 | 0 | 4 |
PE | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 1 |
NL | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 2 |
YT | 5 | 0 | 4 | 1 | 0 | 29 | 0 | 28 | 1 | 0 | 29 |
NT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NU | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Canada | 172 | 2 | 108 | 62 | 9 | 653 | 11 | 507 | 135 | 49 | 702 |
PercentageTable Figure 3 - Footnote 2 | 95% | 1% | 63% | 36% | 5% | 93% | 2% | 78% | 21% | 7% | 100% |
To date this season, detailed information on age and type/subtype has been received for over 643 laboratory confirmed influenza cases. Adults aged 65+ accounted 44% of reported influenza cases. Among cases of influenza A(H3N2), adults aged 65+ accounted for 47% of cases.
Age groups (years) | Weekly (November 6, 2016 to November 12, 2016) | Cumulative (August 28, 2016 to November 12, 2016) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Influenza A | B | Influenza A | B | Influenza A and B | ||||||||
A Total | A(H1) pdm09 | A(H3) | ATable 1 - Footnote UnS | Total | A Total | A(H1) pdm09 | A(H3) | ATable 1 - Footnote UnS | Total | # | % | |
<5 | >6 | 0 | <5 | 6 | <5 | 48 | 0 | 30 | 18 | 12 | 60 | 9% |
5-19 | 17 | 0 | 7 | 10 | <5 | 60 | 0 | 48 | 12 | <5 | >60 | 9% |
20-44 | 17 | 0 | 7 | 10 | <5 | >112 | <5 | 89 | 23 | 9 | >121 | 18% |
45-64 | >18 | <5 | 13 | 5 | <5 | >126 | <5 | 93 | 33 | 7 | >133 | 20% |
65+ | 37 | 0 | 20 | 17 | <5 | >290 | <5 | 229 | 61 | 11 | >301 | 44% |
Total | 101 | <5 | 51 | 48 | 7 | 643 | 7 | 489 | 147 | >39 | >643 | 100% |
PercentageTable 1 - Footnote 2 | 94% | 6% | 94% | 1% | 76% | 23% | 6% | |||||
Syndromic/Influenza-like Illness Surveillance
Healthcare Professionals Sentinel Syndromic Surveillance
In week 45, 1.6% of visits to healthcare professionals were due to ILI. The proportion of ILI visits increased slightly from the previous week.
Figure 4 - Percentage of visits for ILI reported by sentinels by report week, Canada, 2016-17
Number of Sentinels Reporting Week 45: 95
Figure 4 - Text Description
Report week | % Visits for ILI |
---|---|
35 | 0.99% |
36 | 0.98% |
37 | 0.99% |
38 | 0.98% |
39 | 0.96% |
40 | 1.04% |
41 | 2.50% |
42 | 1.08% |
43 | 1.02% |
44 | 1.40% |
45 | 1.63% |
46 | |
47 | |
48 | |
49 | |
50 | |
51 | |
52 | |
1 | |
2 | |
3 | |
4 | |
5 | |
6 | |
7 | |
8 | |
9 | |
10 | |
11 | |
12 | |
13 | |
14 | |
15 | |
16 | |
17 | |
18 | |
19 | |
20 | |
21 | |
22 | |
23 | |
24 | |
25 | |
26 | |
27 | |
28 | |
29 | |
30 | |
31 | |
32 | |
33 | |
34 |
Are you a primary healthcare practitioner (General Practitioner, Nurse Practitioner or Registered Nurse) interested in becoming a FluWatch sentinel?
Please visit our Influenza Sentinel page for more details.
Influenza Outbreak Surveillance
In week 45, two laboratory confirmed influenza outbreaks were reported: one in a long-term care (LTC) facility and one in a hospital. Additionally, one ILI outbreak was reported in a school. Of the outbreaks with known types or subtypes, the outbreak reported in a hospital was due to influenza A (unsubtyped). To date this season, 32 outbreaks have been reported and the majority (66%) have occurred in LTC facilities.
Figure 5 - Text Description
Report week | Hospitals | Long Term Care Facilities | Other |
---|---|---|---|
35 | 0 | 0 | 0 |
36 | 0 | 0 | 0 |
37 | 0 | 2 | 0 |
38 | 1 | 1 | 0 |
39 | 1 | 3 | 0 |
40 | 0 | 0 | 0 |
41 | 0 | 3 | 0 |
42 | 0 | 3 | 0 |
43 | 0 | 3 | 0 |
44 | 2 | 5 | 0 |
45 | 1 | 1 | 0 |
46 | 0 | 0 | 0 |
47 | 0 | 0 | 0 |
48 | 0 | 0 | 0 |
49 | 0 | 0 | 0 |
50 | 0 | 0 | 0 |
51 | 0 | 0 | 0 |
52 | 0 | 0 | 0 |
1 | 0 | 0 | 0 |
2 | 0 | 0 | 0 |
3 | 0 | 0 | 0 |
4 | 0 | 0 | 0 |
5 | 0 | 0 | 0 |
6 | 0 | 0 | 0 |
7 | 0 | 0 | 0 |
8 | 0 | 0 | 0 |
9 | 0 | 0 | 0 |
10 | 0 | 0 | 0 |
11 | 0 | 0 | 0 |
12 | 0 | 0 | 0 |
13 | 0 | 0 | 0 |
14 | 0 | 0 | 0 |
15 | 0 | 0 | 0 |
16 | 0 | 0 | 0 |
17 | 0 | 0 | 0 |
18 | 0 | 0 | 0 |
19 | 0 | 0 | 0 |
20 | 0 | 0 | 0 |
21 | 0 | 0 | 0 |
22 | 0 | 0 | 0 |
23 | 0 | 0 | 0 |
24 | 0 | 0 | 0 |
25 | 0 | 0 | 0 |
26 | 0 | 0 | 0 |
27 | 0 | 0 | 0 |
28 | 0 | 0 | 0 |
29 | 0 | 0 | 0 |
30 | 0 | 0 | 0 |
31 | 0 | 0 | 0 |
32 | 0 | 0 | 0 |
33 | 0 | 0 | 0 |
34 | 0 | 0 | 0 |
Provincial/Territorial Influenza Hospitalizations and Deaths
In week 45, a total of 16 influenza-associated hospitalizations and less than five ICU admissions were reported by participating provinces and territoriesFootnote *. All hospitalizations in week 45 with subtype information available were due to influenza A(H3N2).
To date this season, 98 hospitalizations have been reported, of which 84% were due to influenza A(H3N2) and 64% were in adults aged 65+. Less than five ICU admissions and deaths have been reported.
Age Groups (years) | Cumulative (August 28, 2016 to November 12, 2016) | ||||||
---|---|---|---|---|---|---|---|
Hospitalizations | ICU Admissions | Deaths | |||||
Influenza A Total | Influenza B Total | Total (#) | Influenza A and B Total | % | Influenza A and B Total | % | |
0-4 | 5 | 0 | 5% | 0 | 0% | 0 | 0% |
5-19 | 7 | <5 | 8% | 0 | 0% | 0 | 0% |
20-44 | 10 | <5 | 11% | 0 | 0% | 0 | 0% |
45-64 | 12 | <5 | 13% | <5 | 50% | 0 | 0% |
65+ | 64 | <5 | 63% | <5 | 50% | <5 | 100% |
Total | 98 | <5 | 100% | <5 | 100% | <5 | 100% |
Sentinel Hospital Influenza Surveillance
Pediatric Influenza Hospitalizations and Deaths
To date this season, 22 laboratory-confirmed influenza-associated pediatric (≤16 years of age) hospitalizations were reported by the Immunization Monitoring Program Active (IMPACT) network. The majority of hospitalizations were due to influenza A(H3N2) (67%).
Influenza Strain Characterizations
During the 2016-17 influenza season, the National Microbiology Laboratory (NML) has characterized 88 influenza viruses [75 A(H3N2), 4 A(H1N1), 9 influenza B].
Strain Characterization ResultsTable 3 - Footnote 1 | Count | Description |
---|---|---|
Influenza A (H3N2) | ||
Antigenically A/Hong Kong/4801/2014-like |
31 | Viruses antigenically similar to A/Hong Kong/4801/2014, the A(H3N2) component of the 2016-17 Northern Hemisphere's trivalent and quadrivalent vaccine. |
GeneticallyTable 3 - Footnote 2 A/Hong Kong/4801/2014-like |
44 | Viruses belonging to genetic group 3C.2a. A/Hong Kong/4801/2014-like virus belongs to genetic group 3C.2a and is the influenza A(H3N2) component of the 2016-17 Northern Hemisphere's trivalent and quadrivalent vaccine. |
Influenza A (H1N1) | ||
A/California/7/2009-like | 4 | Viruses antigenically similar to A/California/7/2009, the A(H1N1) component of the 2016-17 Northern Hemisphere's trivalent and quadrivalent vaccine influenza vaccine. |
Influenza B | ||
B/Brisbane/60/2008-like (Victoria lineage) |
7 | Viruses antigenically similar to B/Brisbane/60/2008, the influenza B component of the 2016-17 Northern Hemisphere's trivalent and quadrivalent influenza vaccine |
B/Phuket/3073/2013-like (Yamagata lineage) |
2 | Viruses antigenically similar to B/Phuket/3073/2013, the additional influenza B component of the 2016-17 Northern Hemisphere quadrivalent influenza vaccine. |
Antiviral Resistance
During the 2016-17 season, the National Microbiology Laboratory (NML) has tested 74 influenza viruses for resistance to oseltamivir and zanamivir and 39 influenza viruses for resistance to amantadine. All 50 viruses weres sensitive to oseltamivir and zanamivir. All 39 influenza A viruses were resistant to amantadine (Table 4).
Virus type and subtype | Oseltamivir | Zanamivir | Amantadine | |||
---|---|---|---|---|---|---|
# tested | # resistant (%) | # tested | # resistant (%) | # tested | # resistant (%) | |
A (H3N2) | 62 | 0 (0%) | 62 | 0 (0%) | 36 | 36 (100%) |
A (H1N1) | 3 | 0 (0%) | 3 | 0 (0%) | 3 | 3 (100%) |
B | 9 | 0 (0%) | 9 | 0 (0%) | N/ATable 4 - Footnote * | N/ATable 4 - Footnote * |
TOTAL | 74 | 0 (0%) | 74 | 0 (0%) | 39 | 39 (100%) |
Provincial and International Influenza Reports
- World Health Organization influenza update
- World Health Organization FluNet
- WHO Influenza at the human-animal interface
- Centers for Disease Control and Prevention seasonal influenza report
- European Centre for Disease Prevention and Control - epidemiological data
- South Africa Influenza surveillance report
- New Zealand Public Health Surveillance
- Australia Influenza Report
- Pan-American Health Organization Influenza Situation Report
- Alberta Health - Influenza Surveillance Report
- BC - Centre for Disease Control (BCCDC) - Influenza Surveillance
- New Brunswick - Influenza Surveillance Reports
- Newfoundland and Labrador - Surveillance and Disease Reports
- Nova Scotia - Flu Information
- Public Health Ontario - Ontario Respiratory Pathogen Bulletin
- Quebec - Système de surveillance de la grippe
- Manitoba - Epidemiology and Surveillance - Influenza Reports
- Saskatchewan - influenza Reports
- PEI - Influenza Summary
FluWatch definitions for the 2016-2017 season
Abbreviations: Newfoundland/Labrador (NL), Prince Edward Island (PE), New Brunswick (NB), Nova Scotia (NS), Quebec (QC), Ontario (ON), Manitoba (MB), Saskatchewan (SK), Alberta (AB), British Columbia (BC), Yukon (YT), Northwest Territories (NT), Nunavut (NU).
Influenza-like-illness (ILI): Acute onset of respiratory illness with fever and cough and with one or more of the following - sore throat, arthralgia, myalgia, or prostration which is likely due to influenza. In children under 5, gastrointestinal symptoms may also be present. In patients under 5 or 65 and older, fever may not be prominent.
ILI/Influenza outbreaks
Note: it is recommended that ILI school outbreaks be laboratory confirmed at the beginning of influenza season as it may be the first indication of community transmission in an area.
Note that reporting of outbreaks of influenza/ILI from different types of facilities differs between jurisdictions.
Influenza/ILI activity level
1 = No activity: no laboratory-confirmed influenza detections in the reporting week, however, sporadically occurring ILI may be reported
2 = Sporadic: sporadically occurring ILI and lab confirmed influenza detection(s) with no outbreaks detected within the influenza surveillance region Footnote †
3 = Localized:
- evidence of increased ILIFootnote * and
- lab confirmed influenza detection(s) together with
- outbreaks in schools, hospitals, residential institutions and/or other types of facilities occurring in less than 50% of the influenza surveillance regionFootnote †
4 = Widespread:
- evidence of increased ILIFootnote * and
- lab confirmed influenza detection(s) together with
- outbreaks in schools, hospitals, residential institutions and/or other types of facilities occurring in greater than or equal to 50% of the influenza surveillance regionFootnote †
Note: ILI data may be reported through sentinel physicians, emergency room visits or health line telephone calls.
Page details
- Date modified: